Practical Considerations in Delivering CAR-T Cell Therapies in Singapore

5 July 2021

Event Name: 

ACTRIS Cell Therapy Lecture Series: Practical Considerations in Delivering CAR-T Cell Therapies in Singapore

Date: 

5 July 2021

Time: 

1 to 2pm

Synopsis: 

Chimeric Antigen Receptor (CAR) T-cell therapy is changing the treatment landscape of haematological malignancies. As these treatments gain regulatory approvals and become an available option to patients meeting disease indications, administrative and logistical challenges in delivering CAR therapy outside of clinical trials have also emerged.

The success of CAR T-cell therapy has brought about much media attention and has led to tremendous excitement. Patients may also assume there will be broad access to cellular therapeutics in a similar fashion as other chemotherapeutic agents. However, there are challenges to make these truly available to them. The process of building cell therapy infrastructure, meeting regulatory requirements, and treating patients with CAR T-cell therapy require significant planning and coordination.

In this webinar, Dr Chen Yunxin will share insights from her time at the Memorial Sloan Kettering Cancer Center, a pioneering and renowned institute in the delivery of CAR T-cell therapy, and how this therapy can be applied to and implemented in the local context.

Speaker

Dr Chen Yunxin
Consultant
Department of Haematology
Singapore General Hospital

Register: 

Click here

 

GO BACK
Top